- Home
- DRTS vs VSTM Comparison
DRTS vs VSTM Comparison
Compare DRTS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- VSTM
- Stock Information
- Founded
- DRTS 2015
- VSTM 2010
- Country
- DRTS Israel
- VSTM United States
- Employees
- DRTS N/A
- VSTM N/A
- Industry
- DRTS Medical/Dental Instruments
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- DRTS Health Care
- VSTM Health Care
- Exchange
- DRTS Nasdaq
- VSTM Nasdaq
- Market Cap
- DRTS 158.4M
- VSTM 132.0M
- IPO Year
- DRTS N/A
- VSTM 2012
- Fundamental
- Price
- DRTS $2.20
- VSTM $4.01
- Analyst Decision
- DRTS Strong Buy
- VSTM Strong Buy
- Analyst Count
- DRTS 3
- VSTM 8
- Target Price
- DRTS $8.00
- VSTM $14.57
- AVG Volume (30 Days)
- DRTS 23.4K
- VSTM 1.3M
- Earning Date
- DRTS 11-22-2024
- VSTM 11-06-2024
- Dividend Yield
- DRTS N/A
- VSTM N/A
- EPS Growth
- DRTS N/A
- VSTM N/A
- EPS
- DRTS N/A
- VSTM N/A
- Revenue
- DRTS N/A
- VSTM $10,000,000.00
- Revenue This Year
- DRTS N/A
- VSTM N/A
- Revenue Next Year
- DRTS N/A
- VSTM $108.05
- P/E Ratio
- DRTS N/A
- VSTM N/A
- Revenue Growth
- DRTS N/A
- VSTM N/A
- 52 Week Low
- DRTS $1.75
- VSTM $2.10
- 52 Week High
- DRTS $3.40
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- DRTS 44.90
- VSTM 60.37
- Support Level
- DRTS $2.20
- VSTM $4.00
- Resistance Level
- DRTS $2.30
- VSTM $4.80
- Average True Range (ATR)
- DRTS 0.08
- VSTM 0.34
- MACD
- DRTS -0.00
- VSTM 0.03
- Stochastic Oscillator
- DRTS 22.22
- VSTM 56.52
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.